Gaining Support for Patient Adherence Programs: Effective Strategies and Measuring Effectiveness

STUDY OVERVIEW

As pharmaceutical and biotechnology companies focus more on improving patient adherence, organizations are searching for ways to boost the effectiveness of their adherence programs. Two hallmarks of successful adherence programs are those with thought out strategies and options and those that measure the effectiveness of their patient adherence programs to drive better outcomes.

Best Practices, LLC undertook this benchmarking research to identify effective tactics and strategies for improving patient adherence. This study also highlights key metrics for measuring adherence program effectiveness, and uses case examples to examine winning approaches for driving adherence.

KEY TOPICS

• Adherence Programs: Strategic and Tactical Options
• Measuring Strategy Effectiveness

KEY METRICS

• Overall, how effective are each of the listed patient adherence activities?
• In your experience, how effective are each of the listed techniques in improving patient adherence?
• From your point-of-view, what has been the primary advancement in patient adherence programs over the past several years that has had the most positive impact on improving medication adherence?
• How important is the use of each type of anonymous and aggregated patient data to the success of your adherence programs?

SAMPLE KEY FINDINGS

• Different Payer Systems Influence Adherence Approach: US focuses on financial support vs. Europe favors behavioral/quality of life change.

METHODOLOGY

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Alkermes; Amgen; Bayer; Biogen; Celgene; Eisai; Genentech; Janssen; Jazz Pharmaceuticals; LEO Pharma; OTSUKA; Sanofi; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.